Pfizer Inc. 8K -

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): October 12, 2010

PFIZER INC.
(Exact name of registrant as specified in its charter)

Delaware
1-3619
13-5315170
(State or other Jurisdiction of incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)

235 East 42nd Street
New York, New York
(Address of principal executive offices)

  
10017
(Zip Code)

Registrant's telephone number, including area code:

(212) 733-2323

(Former Name or Former Address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[  ] Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[X] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



Item 8.01

 

Other Events.

On October 12, 2010, Pfizer Inc. ("Pfizer") issued a press release, announcing the execution of an Agreement and Plan of Merger, dated as of October 11, 2010, by and among Pfizer, Parker Tennessee Corp., a wholly-owned subsidiary of Pfizer and King Pharmaceuticals, Inc.  A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

 

 

Item 9.01 Financial Statements and Exhibits.  
(d) Exhibits
    
     
Exhibit No. Description  
99.1 Press Release dated October 12, 2010.  

SIGNATURE

Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.

   
PFIZER INC.
     
   
By: /s/  Matthew Lepore
Matthew Lepore
   
Title: Vice President, Chief Counsel - Corporate Governance, and Assistant General Counsel
Dated: October 12, 2010    

 

 

PFIZER INC.
FORM 8-K
CURRENT REPORT INDEX

EXHIBIT INDEX

Exhibit No.

 Description
99.1 Press Release dated October 12, 2010.